Cargando…
VEGF is associated with the poor survival of patients with prostate cancer: a meta-analysis
BACKGROUND: Vascular endothelial growth factor (VEGF) is considered as a prime mediator of angiogenesis, and has been implicated in carcinogenesis and metastasis. Various studies examined the relationship between VEGF overexpression with the clinical outcome in patients with prostate cancer, but yie...
Autores principales: | Zhan, Ping, Ji, Ya-Nan, Yu, Li-Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708223/ https://www.ncbi.nlm.nih.gov/pubmed/26816732 http://dx.doi.org/10.3978/j.issn.2223-4683.2013.06.03 |
Ejemplares similares
-
VEGF Overexpression Predicts Poor Survival in Hepatocellular Carcinoma
por: Choi, Sae Byeol, et al.
Publicado: (2017) -
Coexpression of TLR9 and VEGF-C is associated with lymphatic metastasis in prostate cancer
por: Zeng, Xian-Zi, et al.
Publicado: (2021) -
Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer
por: Kut, C, et al.
Publicado: (2007) -
Upregulation of microRNA-191 can serve as an independent prognostic marker for poor survival in prostate cancer
por: Liu, Jing-bo, et al.
Publicado: (2019) -
Associations of nm23H1, VEGF-C, and VEGF-3 Receptor in Human Prostate Cancer
por: Yang, Zui-Su, et al.
Publicado: (2014)